共 180 条
[1]
Yang W(2013)Serum lipids and lipoproteins in Chinese men and women Circulation 125 2212-21
[2]
Xiao J(2014)2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults Circulation 129 S1-45
[3]
Yang Z(2014)National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1–executive summary J Clin Lipidol 8 473-88
[4]
Ji L(2004)Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999 Circulation 110 1236-44
[5]
Jia W(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins Lancet 366 1267-78
[6]
Weng J(2014)Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS) Atherosclerosis 235 463-9
[7]
Stone NJ(2007)Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials J Am Coll Cardiol 50 409-18
[8]
Robinson JG(2007)Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy Clin Ther 29 253-60
[9]
Lichtenstein AH(2011)Statin-associated rhabdomyolysis: is there a dose–response relationship? Can J Cardiol 27 146-51
[10]
Bairey Merz CN(2012)Determinaton of alpha-linolenic acid in Yirui capsule by gas chromatography China Food Industry 7 65-7